Perfromance Wealth Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-343
Closed -$201K 206
2024
Q3
$201K Buy
+343
New +$194K 0.01% 187
2024
Q1
Sell
-8,203
Closed -$4.32M 182
2023
Q4
$4.32M Buy
8,203
+676
+9% +$361K 0.19% 42
2023
Q3
$3.8M Buy
7,527
+833
+12% +$410K 0.18% 45
2023
Q2
$3.15M Buy
6,694
+769
+13% +$376K 0.15% 50
2023
Q1
$2.8M Buy
5,925
+1,316
+29% +$635K 0.14% 50
2022
Q4
$2.44M Buy
4,609
+28
+0.6% +$14.8K 0.15% 49
2022
Q3
$2.31M Sell
4,581
-53
-1% -$27.9K 0.13% 44
2022
Q2
$2.38M Sell
4,634
-56
-1% -$28.1K 0.13% 45
2022
Q1
$2.39M Buy
4,690
+264
+6% +$127K 0.1% 50
2021
Q4
$2.22M Buy
+4,426
New +$2M 0.09% 56

Other funds holding UNH

Perfromance Wealth Partners's UNH Position: Q4 2024 in Review

Perfromance Wealth Partners sold out of UnitedHealth (UNH) in Q4 2024, closing a stake of 343 shares — an estimated $201K sold.

Perfromance Wealth Partners first reported a position in UNH in Q4 2021 and held it in 10 quarters. The position peaked at $4.32M in Q4 2023. 3,674 funds tracked by Wall St. Rank hold UNH as of Q4 2024.

  • Perfromance Wealth Partners reported no remaining UnitedHealth position as of Q4 2024 after selling out during the quarter.
  • Perfromance Wealth Partners sold 343 UnitedHealth shares in Q4 2024, an estimated $201K.
  • Perfromance Wealth Partners first reported a position in UnitedHealth in Q4 2021 and held it in 10 quarters.
  • Perfromance Wealth Partners's UnitedHealth position peaked at $4.32M in Q4 2023.
  • 3,674 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2024.

Based on Perfromance Wealth Partners's 13F filing for Q4 2024, filed 17 Jan 2025.